Not being as closely scrutinized as the air max 90 homme pas cher pharmaceutical industry has its advantages. But now the medical device industry wants a little attention. Industry insiders and lobbyists are concerned that the renewal of the Medical Device User Fee and Modernization Act (MDUFMA) will occur in step with the renewal of the Prescription User Drug Fee Act (PDUFA). Both acts expire at the end of the fiscal year and are cruicial to ensuring that FDA has enough money to review new products. But as disputes between congressional Democrats and pharma continue to brew, chances are good that reauthorization of PDUFA — and therefore, MDUFMA; the two move through the legislative process simultaneously — will be delayed. Another concern is that med device firms could be held to the same strict safety standards that are likely to befall pharma. The Hill has more.http://www.sneaker2018.fr/